A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins

European Journal of Heart Failure

Volumn 7, Issue 5, 2005, Pages 927-930

  Chen Scarabelli, Carol ^a   Hughes, Siân E ^b   Landon, Giorgio ^b   Rowley, Peter ^b   Allebban, Zuhair ^c   Lawson, Noel ^c   Saravolatz, Louis ^c   Gardin, Julius ^c   Latchman, David ^d   Scarabelli, Tiziano M ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Caspase activation; Cleavage of myofibrillary proteins; Ephedra; Lipofuscin accumulation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ACTIN; ALPHA ACTININ; ANOREXIGENIC AGENT; CASPASE; EPHEDRA EXTRACT; FLUOXETINE; LIPOFUSCIN; MUSCLE PROTEIN; NICOTINE; TROPONIN T; UNCLASSIFIED DRUG; XENADRIN;

ADULT; APOPTOSIS; ARTICLE; BASOPHIL DEGRANULATION; CASE REPORT; CELL VACUOLE; DEGENERATIVE DISEASE; ENZYME ACTIVATION; FEMALE; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; MUSCLE CELL; PATIENT EDUCATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHOCK; SYNCOPE; VOMITING;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CASPASES; EPHEDRA; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIPOFUSCIN; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; TROPONIN T;

EID: 23744448443     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.09.012     Document Type: Article

References (14)

1. E. Wooltorton, and B. Sibbald Ephedra/ephedrine: cardiovascular and CNS effects CMAJ 166 2002 (Mar. 5) 5
2. S. Bent, T.N. Toedt, M.C. Odden, and M.G. Shlipak The relative safety of ephedra compared with other herbal products Ann. Intern. Med. 138 2003 468 471
3. J.M. Torpy Ephedra and ephedrine JAMA 289 12 2003 1590
4. C.A. Haller, and N.L. Benowitz Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids N. Engl. J. Med. 343 25 2000 1833 1838
5. Xenadrin Product Info (Cytodyne Technologies). Available at http://www.musclesurf.com. Accessed 5/12/03.
6. D. Samenuk, M.S. Link, and M.K. Homoud Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine Mayo Clin. Proc. 77 2002 12 16
7. T. Scarabelli, A. Stephanou, and N. Rayment Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury Circulation 104 2001 253 256
8. T.M. Scarabelli, A. Stephanou, and E. Pasini Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury Circ. Res. 90 2002 745 748
9. M. Nakano, F. Oenzil, T. Mizuno, and S. Gotoh Age-related changes in lipofuscin accumulation of brain and heart Gerontology 41 Suppl. 2 1995 69 79
10. D.H. Koobs, R.L. Schultz, and R.V. Jutzky The origin of lipofuscin and possible consequences to the myocardium Arch. Pathol. Lab. Med. 102 2 1978 (Feb) 66 81
11. K. Singh, L. Xiao, A. Remondino, D.B. Sawyer, and W.S. Colucci Adrenergic regulation of cardiac myocyte apoptosis J. Cell. Physiol. 189 3 2001 257 265
12. D.R. Green Apoptotic pathways: the roads to ruin Cell 94 6 1998 695 698
13. C. Communal, M. Sumandea, P. de Tombe, J. Narula, R.J. Solaro, and R.J. Hajjar Functional consequences of caspase activation in cardiac myocytes Proc. Natl. Acad. Sci. U. S. A. 99 9 2002 6252 6256
14. T.M. Scarabelli, E. Pasini, and G. Ferrari Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells J. Thorac. Cardiovasc. Surg. 128 2004 364 371